AzTrials
AzTrials

LonelinessNCT05394389

The Complementary Contributions of Sensory Stimulation and Social Support During Snoezelen Room Therapy on the General Physical and Emotional Health of the Elderly Population: Optimization of the Nursing Home Resources.

A study testing sensory stimulating therapy and social support in people with Loneliness and Aging, run by Pavel Goldstein at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Over time, lifespan is extending, the population is aging, and accordingly there is a great demand for hospital beds in nursing homes, increasing attention to this population and the services they receive. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Loneliness, Aging
What is being tested?
sensory stimulating therapy and social support
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteIsrael
Study dates
1 Jan 2022to 30 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Patients living in the Ahuzat Moriah nursing home\ geriatric nursing hospital in Shefar'am.

Who cannot join

  • Patients with epilepsy and aggressive patients. *We do not limit the participation of patients whose cognitive level is very low.

Trial locations and contacts

1 site in 1 country.

Pavel Goldstein, PhD contact

0542488445

pavelg@stat.haifa.ac.il

Sewar R Khatib, MHA contact

sewar94@outlook.com

Israel1 site, 1 recruiting
  • Ahuzat Moriah Shfraam

    Haifa, North, 2020000

    sewar r khatib, MHA student, 0509967091 ext. AM, sewar94@gmail.com

    Recruiting

Other trials in Israel

About this study

Over time, lifespan is extending, the population is aging, and accordingly there is a great demand for hospital beds in nursing homes, increasing attention to this population and the services they receive. Mostly, elderly population living in nursing homes suffers from dementia, Alzheimer, depression, agitation, and other diseases that require multidisciplinary treatment.

In addition to the medical and pharmacological treatments that patients receive to maintain functional medical status, there is a great need for non-pharmacological treatments, that may improve quality of life, mental well-being, and life satisfaction.

Read more

There are several treatment approaches of multisensory stimulation environment (MSSE). MSSE in the Snoezelen room therapy recognized as benefiting the patients' physical, mental, and emotional health status. In addition, there is great importance of intervention by social interaction, support, and encouragement.

However, the effect of combined intervention of MSSE in Snoezelen room therapy and social support, has not yet been sufficiently studied in elderly patients in nursing homes. These two interventions - together - are supposed to have an increased effect on physical and mental wellbeing of elderly.

Conditions
Loneliness, Aging
Being tested
sensory stimulating therapy, social support

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sensory stimulating therapyOther

    Also called integrative approach sensory stimulating therapy and social support

    therapy session in the snoozlen room accompanied by social support.

  • social supportOther

    ten minutes of conversing.

Study groups in NCT05394389
Study groupRoleWhat they receive
sensory-stimulating therapyActive comparatorNot described
Receives: Other: sensory stimulating therapy
social interactionActive comparatorNot described
Receives: Other: social support
combined sensory-stimulating therapy and social interaction.ExperimentalNot described
Receives: Other: sensory stimulating therapy; Other: social support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain, patient- reported outcome, measured by a ruler from zero to 10, on the Likert scale

    An interval variable measured by a ruler from zero to 10, on the Likert scale, and with the help of illustrations of faces, the farther away from zero, the higher the intensity of pain.

    Measured: four weeks

  2. grip strength

    A continuous quantitative variable presented in numerical values of isometric grip force from 0 to 90 kg and will be measured by Jamar hydraulic dynamometer. The hand grip strength will be measured in a hydraulic dynamometer borrowed from the university. The assessment does not involve any potential damage, a two-minute test in which the subject is required to press a device to measure grip strength.

    Measured: eighteen minutes

  3. life satisfaction, patient-reported outcome.

    using the SWLS questionnaire before the first session and after the fourth(last) session as an estimation tool .Interval variable, showing scores ranging from 5-35, on the Likert scale, the higher the score it indicates more life satisfaction.

    Measured: four weeks

  4. general anxiety disorder, patient- reported outcome

    using the GAD questionnaire before the first session and after the fourth(last) session as an estimation tool.GAD- is an interval variable, which will be measured using the sum of the reports on the 7 statements on the Likert scale from 0 to 3, the higher the score on this questionnaire, the higher the level of anxiety among the patient. The total score range is from 0-21.

    Measured: four weeks

  5. blood pressure

    Continuous quantitative variable, will be measured by a blood pressure monitor "Welch Allyn" measuring instrument\ device and quantitatively represented, this result variable will examine the quantitative change in systolic and diastolic blood pressure.

    Measured: eighteen minutes

Secondary outcomes (2)
  1. pulse(heart rate index)

    Continuous quantitative variable, will be measured by "Welch Allyn" measuring instrument\ device.

    Measured: eighteen minutes

  2. oxygen saturation

    Continuous quantitative variable, will be measured by "Welch Allyn" measuring instrument\ device. and presents the degree of oxygen concentration in the blood.

    Measured: eighteen minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2022
  2. Study start1 Jan 2022
  3. Primary completion15 Jul 2022 (estimated)
  4. Study completion30 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05394389
Sponsor's protocol ID
Upshaifa
Status last verified
May 2022
First submitted
23 May 2022
Last updated
27 May 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Khatib S, Palgi Y, Ashar YK, Polyvyannaya N, Goldstein P. The Combined Effect of Multisensory Stimulation and Therapist Support on Physical and Mental Health of Older Adults Living in Nursing Homes: Pilot Randomized Controlled Trial. J Med Internet Res. 2025 Jan 14;27:e55042. doi: 10.2196/55042.

    PubMed 39808474

Questions about this trial

What is this clinical trial studying?

A study testing sensory stimulating therapy and social support in people with Loneliness and Aging, run by Pavel Goldstein at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pavel Goldstein, PhD (0542488445, pavelg@stat.haifa.ac.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain, patient- reported outcome, measured by a ruler from zero to 10, on the Likert scale (time frame: four weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05394389, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in